M3, Inc.

OTC
MTHRY
Stock
Yield per half year: +24.84%
Dividend yield: 1.16%
Sector: Healthcare

M3, Inc.

8.008.007.007.006.006.005.005.004.004.00Oct '24Oct '24Nov '24Nov '24Dec '24Dec '2420252025Feb '25Feb '25Mar '25Mar '25Apr '25Apr '25May '25May '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25

Underestimation

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
10/10
0.258 46.56 -99.45% 6.8 -96.21%
P/S 0.0367 4.29 -99.14%
P/BV 0.0276 5.34 -99.48%
P/FCF 0.2444 27.86 -99.12%
Ev/Ebitda 13 17.57 -26.05%
Ev/S 3.54 4.42 -19.76%
Ev/FCF 23.62 40.58 -41.8%
E/P 3.88 1.1 254.31%

Efficiency

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
8/10
27.28 23.09 18.12% 33.09 -17.58%
ROE 10.7 14.32 -25.29%
ROA 6.96 7.27 -4.3%
ROIC 16.07 14.12 13.82%
ROS 14.21 10.85 30.96%
ROCE 15.87 17.52 -9.4%

Debt

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
10/10
0.3143 2.87 -89.06% 0.1899 +65.5%
Nеt Debt/Ebitda -1.42 0.0129 -11164.64%
Debt/Ratio 0.042 0.2142 -80.4%
Debt/Equity 0.4093 1.11 -63.05%
Debt/Net Income 0.6032 8.89 -93.21%

Dividends

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
2.9/10
1.16 1.61 -27.95% 0.7219 +60.7%
Number of years of dividend growth 4 1.68 138.1%
DSI 1 0.7823 27.82%
Average dividend growth 9.16 -397.13 -102.31%
Average percentage for 5 years 0.7219 3.27 -77.9%
Average percentage for payments 24.66 150.93 -83.66%
Difference from average difference in sector -0.45

Growth impulse

Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue in 5 years
8/10
68.38 337.08 -79.71%
Growth impulse Ebitda in 5 years 21.23 382.84 -94.45%
Growth impulse Net Income in 5 years 7.04 233.81 -96.99%
Growth impulse FCF in 5 years -4.23 215.4 -101.96%
Growth impulse EPS in 5 years 4536.93 418.39 984.38%
IP Score
6.62/10

Similar companies

Sinopharm Group Co., Ltd.

WuXi Biologics (Cayman) Inc.

Roche Holding

Sinopharm Group Co., Ltd.

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription